Your browser doesn't support javascript.
loading
Variations in the Human Serum Albumin Gene: Molecular and Functional Aspects.
Caridi, Gianluca; Lugani, Francesca; Angeletti, Andrea; Campagnoli, Monica; Galliano, Monica; Minchiotti, Lorenzo.
Afiliación
  • Caridi G; UOC Nefrologia e Trapianto Rene, Laboratorio di Nefrologia Molecolare, Istituto Giannina Gaslini IRCCS, 16147 Genova, Italy.
  • Lugani F; UOC Nefrologia e Trapianto Rene, Laboratorio di Nefrologia Molecolare, Istituto Giannina Gaslini IRCCS, 16147 Genova, Italy.
  • Angeletti A; UOC Nefrologia e Trapianto Rene, Laboratorio di Nefrologia Molecolare, Istituto Giannina Gaslini IRCCS, 16147 Genova, Italy.
  • Campagnoli M; Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.
  • Galliano M; Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.
  • Minchiotti L; Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.
Int J Mol Sci ; 23(3)2022 Jan 21.
Article en En | MEDLINE | ID: mdl-35163085
ABSTRACT
The human albumin gene, the most abundant serum protein, is located in the long arm of chromosome 4, near the centromere, position 4q11-3. It is divided by 14 intervening introns into 15 exons, the last of which is untranslated. To date, 74 nucleotide substitutions (mainly missense) have been reported, determining the circulating variants of albumin or pre-albumin. In a heterozygous state, this condition is known as alloalbuminaemia or bisalbuminaemia (OMIM # 103600). The genetic variants are not associated with disease, neither in the heterozygous nor in the homozygous form. Only the variants resulting in familial dysalbuminaemic hyperthyroxinaemia and hypertriiodothyroninaemia are of clinical relevance because affected individuals are at risk of inappropriate treatment or may have adverse drug effects. In 28 other cases, the pathogenic variants (mainly affecting splicing, nonsense, and deletions), mostly in the homozygous form, cause a premature stop in the synthesis of the protein and lead to the condition known as congenital analbuminaemia. In this review, we will summarize the current knowledge of genetic and molecular aspects, functional consequences and potential therapeutic uses of the variants. We will also discuss the molecular defects resulting in congenital analbuminaemia, as well as the biochemical and clinical features of this rare condition.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Intrones / Hipoalbuminemia / Albúmina Sérica Humana / Homocigoto / Mutación Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Intrones / Hipoalbuminemia / Albúmina Sérica Humana / Homocigoto / Mutación Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: Italia